Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Pediatr Allergy Immunol ; 33 Suppl 27: 38-40, 2022 01.
Article in English | MEDLINE | ID: covidwho-1779268

ABSTRACT

Airborne particulate (PM) components from fossil fuel combustion can induce oxidative stress initiated by reactive oxygen species (ROS) that are strongly correlated with airway inflammation and asthma. A valid biomarker of airway inflammation is fractionated exhaled nitric oxide (FENO). The oxidative potential of PM2.5 can be evaluated with the dithiothreitol (DTT) dosage, which represents both ROS chemically produced and intracellular ROS of macrophages. This correlates with quality indicators of the internal environment and ventilation strategies such as dilution and removal of airborne contaminants.


Subject(s)
Air Pollutants , Air Pollution , Asthma , Air Pollutants/analysis , Air Pollutants/toxicity , Air Pollution/statistics & numerical data , Exhalation , Humans , Oxidative Stress , Particulate Matter/toxicity
2.
Pediatr Allergy Immunol ; 31 Suppl 26: 26-28, 2020 11.
Article in English | MEDLINE | ID: covidwho-944772

ABSTRACT

Respiratory allergies are known to affect people all over the world. Environmental factors related to pollution play a significant etiopathogenic role in this regard. Polluting sources are industrial activities and urban traffic, capable of generating various types of pollutants that trigger inflammatory, direct, and indirect damage to tissues, promoting allergic symptoms, even serious ones, and interfering with the pharmacologic response. They are also able to modify pollen, promoting allergic sensitization. Pollution could have played a significant predisposing role in the ongoing morbidity and mortality of SARS-CoV-2.


Subject(s)
Air Pollution/adverse effects , COVID-19/epidemiology , Respiratory Hypersensitivity/etiology , SARS-CoV-2 , Child , Humans , Nitrogen Dioxide/adverse effects , Ozone/adverse effects , Particulate Matter/adverse effects
3.
Ital J Pediatr ; 46(1): 84, 2020 Jun 16.
Article in English | MEDLINE | ID: covidwho-599459

ABSTRACT

The COVID-19 pandemic has surprised the entire population. The world has had to face an unprecedented pandemic. Only, Spanish flu had similar disastrous consequences. As a result, drastic measures (lockdown) have been adopted worldwide. Healthcare service has been overwhelmed by the extraordinary influx of patients, often requiring high intensity of care. Mortality has been associated with severe comorbidities, including chronic diseases. Patients with frailty were, therefore, the victim of the SARS-COV-2 infection. Allergy and asthma are the most prevalent chronic disorders in children and adolescents, so they need careful attention and, if necessary, an adaptation of their regular treatment plans. Fortunately, at present, young people are less suffering from COVID-19, both as incidence and severity. However, any age, including infancy, could be affected by the pandemic.Based on this background, the Italian Society of Pediatric Allergy and Immunology has felt it necessary to provide a Consensus Statement. This expert panel consensus document offers a rationale to help guide decision-making in the management of children and adolescents with allergic or immunologic diseases.


Subject(s)
Allergy and Immunology , Betacoronavirus , Consensus , Coronavirus Infections/therapy , Disease Management , Pandemics , Pneumonia, Viral/therapy , Societies, Medical , Adolescent , COVID-19 , Child , Coronavirus Infections/epidemiology , Decision Making , Humans , Italy/epidemiology , Pneumonia, Viral/epidemiology , Pragmatic Clinical Trials as Topic/methods , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL